Thankyou for that. I am rightly impressed with this comp having the 31% approx instit. Support( their research is the most reliable of all, it would seem and what small biotech has even one to ten % instit. Supp. ?!?) been trying to grasp the stock for a few days. Not a lot of insider buying; and the amazing way that little fragment of matter can bond onto the inside of a capillary and block blood profusion and calcium damages at that location. So impressed at its impact on inflamm process and that there's only one other drug for sickle cell acute process( that doesn't really address the prob at its roots). The fact that this can be used for heart trauma at time of attack leads meto belief thatt can have have same impact for infarct or other capillary bed blockage anywhere in the body. Sickle cell would be the benefactor of the platforms research which may address the entire body, dumbfounding impact, a matter of research studies on every part of the body, every organ that receives blood flow, in other words, every organ. The platform is beyond stunning for all the benefit to man and medicine, to say nothing of the real financial impact over time. Billions is on the very light side over time if the SC epic works. A looooong term hold, tho the shorts will make it not a smooth ride. No debt for as far as they've traveled, is so promising, maybe genius if looking from the perspective of a parent of a little child who is hospitalized two times a year for SC acute attacks. The great pharmas can hardly boast as clear an early path.
But I want to see what people here say about accus. That management is selling down into the .40s and what are some responses to the current alpha report. Having trouble downloading it. Also, my phone calls to company over last few days go to answer machine so I am putting the question out to some serious longs here re the proprietary nature of this cleanup of the material, that is the main component the epic study is based on. If it worked on pigs it could possibly work on humans, who could actually report side effects. Can't believe a second dosing will sustain the cardiac benefits for an even longer time, connoting genuine cellular and chemical healing over that first month. I remain curious as to whether one could start with a similar polymer, clean it up using another method and apply it to the body in similar fashion and have that full boatload of remarkable impacts of the mast product. What is being patented? The non proprietary name of the cleaned , engineered substance is easy to understand. It should not be replaced with any other non cleaned substance. But that does not tell me if another company can engineer a new cleanup method and legitimately apply that material for all the same benefits and financial gain. All this effort over all these strategic years would be as much as pirated if there fails to be something chemically different, that cannot be legitimately redone. Everything else appears pristine. I'll just wait for comp to return my call as it needs person to person conversation, in order to get the feel. Epic is incorporating some really substantial hospitals which could get their hands on any brilliant research studies. FDA does not grant fast track to any fly by night entity and this is not some bare minimum orphan candidate. We just don't hear so much about sickle cell here in the USA. But it is a vey tragic disease of huge proportions world wide even tho the focus is not white Anglos. Not interested in politicos . People might enjoy the 12 videos on the same website you provided that takes varied SC victims over years thru their life experiences with the disease. Remarkably humanitarian! Thankyou again for your response. GLT ALL GENUINE LONGS. This could be world changing over time with such a potentially broad platform and bright scientists creating such a diverse pipeline application. Not an advisor, all said IMO. Have a great weekend and would like hearing others' input.
